“…Eight studies exclusively utilized tDCS as the therapeutic tool [ 33 - 40 ], 23 studies utilized solely rTMS as the therapeutic tool [ 41 - 63 ], and one study used both rTMS and tDCS to evaluate their therapeutic effects on ASD [ 64 ]. Six of the included articles were case-reports [ 35 , 40 , 43 , 47 , 49 , 53 ], nine were non-controlled trials [ 36 , 37 , 41 , 46 , 55 , 57 , 61 , 62 , 64 ], and the remaining 17 were controlled trials [ 33 , 34 , 38 , 39 , 42 , 44 , 45 , 48 , 50 - 52 , 54 , 56 , 58 - 60 , 63 ]. Eleven of the controlled studies used a sham group as the control [ 33 , 34 , 38 , 39 , 42 , 48 , 50 - 52 , 54 , 63 ] and the remaining six compared neuromodulated patients with waitlist controls.…”